Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma
- 18 November 2003
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 202 (1) , 86-94
- https://doi.org/10.1002/path.1489
Abstract
Malignant transformation of parathyroid tumours is rare. Nevertheless, this small subset of malignant tumours often creates diagnostic and therapeutic problems. In this work, the morphological characteristics of 26 primary parathyroid carcinomas and seven metastases have been studied. Furthermore, immunohistochemical expression profiles for the calcium sensing receptor (CASR), cyclin D1 (CCND1), and Ki‐67 were determined for parathyroid carcinomas and compared with adenomas and hyperplasias using a tissue microarray. Loss of heterozygosity (LOH) of the chromosome 1q region containing the HRPT2 gene and chromosome 11q (MEN1) was determined in the carcinomas. In contrast to the adenomas and hyperplasias, 31% of carcinomas demonstrated down‐regulation of CASR. A significant correlation was found between CASR expression and the Ki‐67 proliferation index. Chromosome 1q and chromosome 11q LOH were found in 12 of 22 (55%) and 11 of 22 (50%) carcinomas tested, respectively. Combined 1q and 11q LOH was seen in 8 of 22 (36%) carcinomas, in contrast to the low percentage of LOH reported in both regions in adenomas. In conclusion, this study demonstrates that combined 1q and 11q LOH in parathyroid tumours is suggestive of malignant behaviour. Strong down‐regulation of the CASR protein is seen in a proportion of parathyroid carcinomas with a high proliferation index. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndromeNature Genetics, 2002
- Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 2000
- No Evidence for Mutations in the Calcium-Sensing Receptor Gene in Sporadic Parathyroid AdenomasJournal of Bone and Mineral Research, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Familial Isolated Hyperparathyroidism Maps to the Hyperparathyroidism-Jaw Tumor Locus in 1q21-q32 in a Subset of FamiliesJournal of Clinical Endocrinology & Metabolism, 1998
- Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid AdenomasJournal of Clinical Endocrinology & Metabolism, 1998
- Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1997
- Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidismHuman Genetics, 1997
- Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical studyJournal of Clinical Endocrinology & Metabolism, 1996
- Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumorsJournal of Clinical Endocrinology & Metabolism, 1995